|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,960,592 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,960,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-61.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-25 |
4 |
AS |
$78.47 |
$126,964 |
D/D |
(1,618) |
67,008 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-29 |
4 |
AS |
$79.43 |
$128,518 |
D/D |
(1,618) |
57,638 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-02 |
4 |
D |
$79.86 |
$128,894 |
D/D |
(1,614) |
58,304 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-11 |
4 |
AS |
$90.31 |
$129,685 |
D/D |
(1,436) |
50,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$130,187 |
D/D |
(1,414) |
51,571 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-09-22 |
4 |
OE |
$37.46 |
$131,897 |
D/D |
3,521 |
50,110 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$133,920 |
D/D |
(1,488) |
59,809 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-05-15 |
4 |
D |
$122.78 |
$134,567 |
D/D |
(1,096) |
40,870 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$134,991 |
D/D |
(1,488) |
48,948 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-03-24 |
4 |
AS |
$74.36 |
$151,769 |
D/D |
(2,041) |
68,626 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-05-05 |
4 |
OE |
$28.23 |
$162,879 |
D/D |
4,486 |
55,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$164,319 |
D/D |
(1,749) |
51,510 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-01-22 |
4 |
AS |
$55.00 |
$165,000 |
D/D |
(3,000) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-06-04 |
4 |
AS |
$122.35 |
$166,646 |
D/D |
(1,362) |
35,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-22 |
4 |
AS |
$81.00 |
$167,913 |
D/D |
(2,073) |
65,385 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-10-14 |
4 |
AS |
$79.91 |
$169,489 |
D/D |
(2,121) |
61,281 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-04-02 |
4 |
AS |
$80.12 |
$169,774 |
D/D |
(2,119) |
52,914 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-06-04 |
4 |
D |
$120.46 |
$179,244 |
D/D |
(1,488) |
36,967 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-07-20 |
4 |
OE |
$63.10 |
$189,300 |
D/D |
3,000 |
38,605 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2020-04-08 |
4 |
AS |
$79.98 |
$192,512 |
D/D |
(2,407) |
63,064 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-10-26 |
4 |
AS |
$73.60 |
$201,590 |
D/D |
(2,739) |
55,853 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2015-05-26 |
4 |
AS |
$126.55 |
$205,647 |
D/D |
(1,625) |
39,245 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$214,520 |
D/D |
(2,395) |
48,137 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-03-04 |
4 |
AS |
$60.00 |
$240,000 |
D/D |
(4,000) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-09 |
4 |
AS |
$82.39 |
$244,863 |
D/D |
(2,972) |
55,332 |
0 |
- |
|
174 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|